These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17934334)

  • 1. Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells.
    Lee EJ; Choi EM; Kim SR; Park JH; Kim H; Ha KS; Kim YM; Kim SS; Choe M; Kim JI; Han JA
    Exp Mol Med; 2007 Aug; 39(4):469-76. PubMed ID: 17934334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis.
    Xu Z; Choudhary S; Voznesensky O; Mehrotra M; Woodard M; Hansen M; Herschman H; Pilbeam C
    Cancer Res; 2006 Jul; 66(13):6657-64. PubMed ID: 16818639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib inhibits invasion and metastasis via a cyclooxygenase 2-independent mechanism in an in vitro model of Ewing sarcoma.
    Barlow M; Edelman M; Glick RD; Steinberg BM; Soffer SZ
    J Pediatr Surg; 2012 Jun; 47(6):1223-7. PubMed ID: 22703797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 inhibition prevents migration of colorectal cancer cells to extracellular matrix by down-regulation of matrix metalloproteinase-2 expression.
    Leung E; McArthur D; Morris A; Williams N
    Dis Colon Rectum; 2008 Mar; 51(3):342-7. PubMed ID: 18228100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitive effect of celecoxib on the adhesion and invasion of human tongue squamous carcinoma cells to extracellular matrix via down regulation of MMP-2 expression.
    Li WZ; Huo QJ; Wang XY; Xu F
    Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):113-9. PubMed ID: 20709621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.
    Duan DP; Dang XQ; Wang KZ; Wang YP; Zhang H; You WL
    Oncol Rep; 2012 Nov; 28(5):1693-700. PubMed ID: 22922684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts.
    Dickens DS; Cripe TP
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):709-14. PubMed ID: 12972806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma.
    Kwak YE; Jeon NK; Kim J; Lee EJ
    Ann N Y Acad Sci; 2007 Jan; 1095():99-112. PubMed ID: 17404023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
    Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
    J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte elevated gene-1 (AEG-1) promotes osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway.
    Wang F; Ke ZF; Wang R; Wang YF; Huang LL; Wang LT
    Biochem Biophys Res Commun; 2014 Oct; 452(4):933-9. PubMed ID: 25204501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibited proliferation of cyclooxygenase-2 expressing human hepatoma cells by NS-398, a selective COX-2 inhibitor.
    Hu KQ; Yu CH; Mineyama Y; McCracken JD; Hillebrand DJ; Hasan M
    Int J Oncol; 2003 Apr; 22(4):757-63. PubMed ID: 12632065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide inhibits invasion/migration in SGC-7901 cells by activating the reactive oxygen species-dependent cyclooxygenase-2/matrix metalloproteinase-2 pathway.
    Liu Y; Zhang W; Zhang X; Qi Y; Huang D; Zhang Y
    Exp Biol Med (Maywood); 2011 May; 236(5):592-7. PubMed ID: 21540248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Columbamine suppresses the proliferation and neovascularization of metastatic osteosarcoma U2OS cells with low cytotoxicity.
    Bao M; Cao Z; Yu D; Fu S; Zhang G; Yang P; Pan Y; Yang B; Han H; Zhou Q
    Toxicol Lett; 2012 Dec; 215(3):174-80. PubMed ID: 23124089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
    Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
    J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells.
    Venkatesan P; Bhutia SK; Singh AK; Das SK; Dash R; Chaudhury K; Sarkar D; Fisher PB; Mandal M
    Life Sci; 2012 Oct; 91(15-16):789-99. PubMed ID: 22922496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
    Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
    Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases participate in osteosarcoma invasion.
    Bjørnland K; Flatmark K; Pettersen S; Aaasen AO; Fodstad O; Maelandsmo GM
    J Surg Res; 2005 Aug; 127(2):151-6. PubMed ID: 16083752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity.
    Li WW; Long GX; Liu DB; Mei Q; Wang JF; Hu GY; Jiang JZ; Sun W; Gan L; Hu GQ
    Pharmazie; 2014 Feb; 69(2):132-7. PubMed ID: 24640603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.